Who is owner of Panacea Biotec?
Who is owner of Panacea Biotec?
Panacea Biotec
| Type | Public |
|---|---|
| Founded | 1984 |
| Headquarters | New Delhi, India |
| Key people | Soshil Kumar (Executive Chairman of the Board), Dr. Rajesh Jain (Managing Director), Sandeep Jain (Joint Managing Director) |
| Products | Pharmaceuticals, generic drugs, vaccine |
Is Panacea Biotec and Serum Institute Same?
Serum Institute of India CEO Adar Poonawalla on Monday offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction.
Is Panacea Biotec a good company?
Panacea Biotec is rated 3.9 out of 5, based on 532 reviews by employees on AmbitionBox. Panacea Biotec is known for Work-Life balance which is rated at the top and given a rating of 3.8. However, Salary & Benefits is rated the lowest at 3.3 and can be improved.
What happened Panacea Biotec?
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2021.
Is Panacea Biotec sold to Mankind Pharma?
Mankind Pharma acquires Panacea Biotec’s domestic formulation brands for India and Nepal. Panacea Biotec and its wholly-owned subsidiary Panacea Biotec Pharma (PBPL) have entered into definitive agreements for sale of pharmaceutical formulations brands of PBPL for India and Nepal, to Mankind Pharma.
Who is owner of Serum Institute of India?
Poonawalla Investments & Industries Pvt. Ltd.Serum Institute of India / Parent organization
Is Serum Institute sold?
Vaccines & immuno-biologicals manufacturer Serum Institute of India sold 3.58 lakh equity shares in Panacea Biotec, representing 0.58 percent of total shareholding on the NSE, as per the bulk deals data. Serum Institute sold those shares at a price of Rs 278.15 per share.
Can I buy Panacea Biotec share?
You can buy Panacea Biotec Ltd shares through a brokerage firm.
Is mankind takeover Panacea Biotec?
Mankind Pharma to acquire Panacea’s formulation brands for ₹1,872 crore. Mankind Pharma will acquire Panacea Biotec Pharma’s formulations brands for ₹1,872 crore, the company said on Monday. Panacea Biotec Pharma Ltd is a wholly-owned subsidiary of Panacea Biotec.
Which company will acquire Panacea Biotec pharma formulations brands for India and Nepal markets for Rs 1872 crore?
Mankind Pharma
Mankind Pharma acquires Panacea Biotec’s domestic formulation brands for India and Nepal. Panacea Biotec and its wholly-owned subsidiary Panacea Biotec Pharma (PBPL) have entered into definitive agreements for sale of pharmaceutical formulations brands of PBPL for India and Nepal, to Mankind Pharma.
Which domestic formulation business we have acquired recently?
Drug maker Aurobindo Pharma on Monday said it has acquired the domestic formulations business of Veritaz for Rs 171 crore on debt free and cash-free basis. This acquisition vehicle will greatly help Aurobindo as a launch pad for marketing biosimilar and other products in India, the company said in a statement.
Which country made Covaxin?
COVAXIN® – India’s First Indigenous COVID-19 Vaccine. COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).